Performance Measurement in the Hospital Outpatient Setting. Synthesis of Measures Relating to Drugs and Biologicals


Few measures were identified that address the use or dosing of drugs and biologicals (based on G, H, and K codes) that are paid separately under OPPS. The vast majority of identified measures address the use of cancer chemotherapy. The identification or development of measures that specifically focus on high-volume drugs and biologics that represent the most significant expense to the Medicare program, such as blood products and contrast material used for imaging for the OPPS and thrombolytic agents in the ED, would be valuable.

View full report


"outpatient.pdf" (pdf, 1001.94Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®